50 likes | 165 Views
Oligonucleotide sequences and PCR conditions used for sequencing. Voso et al, Supplementary Figure 1. Exemplary sequencing reactions for all genes studied. Voso et al, Supplementary Figure 2. Time to Leukemic evolution. SRSF2-mutated. SRSF2-wild type. Probability (%). p=0.04.
E N D
Oligonucleotide sequences and PCR conditions used for sequencing Voso et al, Supplementary Figure 1
Exemplary sequencing reactions for all genes studied Voso et al, Supplementary Figure 2
Time to Leukemic evolution SRSF2-mutated SRSF2-wild type Probability (%) p=0.04 Months from MPN diagnosis Voso et al, Supplementary Figure 3
Characteristics of patients with leukemias secondary to chronic myeloproliferative neoplasms *Of 5 patients with a complex karyotype, 2 had 11q23 abnormalities and 3 had a chromosome 5 and/or 7 deletion Voso et al, Supplementary Table 1
Prevalence of mutations in patients with leukemias Secondary to chronic myeloproliferative neoplasms * One patient with a previous PV had synchronous IDH2 R140Q and DNMT3A R882H mutations ** p=0.025 Voso et al, Supplementary Table 2